| Priya Patel, | |
|
1717 6th Ave S, Birmingham, AL 35233-1801 | |
| (800) 822-8816 | |
| Not Available |
| Full Name | Priya Patel |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 1717 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346755196 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SG0600X | Clinical Nurse Specialist - Gerontology | 1-149581 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Charles River Laboratories International, Inc. announced today that it has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost efficient basis, the repurchase of a substantial number of its shares pursuant to that stock repurchase authorization.
In a study published in the journal PNAS scientists of the German Center for Neurodegenerative Diseases present new findings on the role of the protein Tau in certain brain diseases.
Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.
Vertex Pharmaceuticals Incorporated today announced that it will receive $155 million in cash from two financial transactions. In the first transaction, Vertex will receive approximately $120 million in cash for the issuance of notes repayable no later than October 31, 2012 in the total amount of $155 million.
National Jewish Health is seeking to refine and improve lung-cancer screening by combining a blood test with CT imaging to detect disease earlier and more effectively. The trial combines a CT chest scan and the EarlyCDT-Lung blood test to screen for cancer, and seeks to build on recent research demonstrating that CT screening alone can reduce lung-cancer mortality.
› Verified 4 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Charles River Laboratories International, Inc. announced today that it has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost efficient basis, the repurchase of a substantial number of its shares pursuant to that stock repurchase authorization.
In a study published in the journal PNAS scientists of the German Center for Neurodegenerative Diseases present new findings on the role of the protein Tau in certain brain diseases.
Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.
Vertex Pharmaceuticals Incorporated today announced that it will receive $155 million in cash from two financial transactions. In the first transaction, Vertex will receive approximately $120 million in cash for the issuance of notes repayable no later than October 31, 2012 in the total amount of $155 million.
National Jewish Health is seeking to refine and improve lung-cancer screening by combining a blood test with CT imaging to detect disease earlier and more effectively. The trial combines a CT chest scan and the EarlyCDT-Lung blood test to screen for cancer, and seeks to build on recent research demonstrating that CT screening alone can reduce lung-cancer mortality.
› Verified 4 days ago
| Entity Name | Helena Family Medicine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215086020 PECOS PAC ID: 7810091485 Enrollment ID: O20070409000634 |
News Archive
Charles River Laboratories International, Inc. announced today that it has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost efficient basis, the repurchase of a substantial number of its shares pursuant to that stock repurchase authorization.
In a study published in the journal PNAS scientists of the German Center for Neurodegenerative Diseases present new findings on the role of the protein Tau in certain brain diseases.
Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.
Vertex Pharmaceuticals Incorporated today announced that it will receive $155 million in cash from two financial transactions. In the first transaction, Vertex will receive approximately $120 million in cash for the issuance of notes repayable no later than October 31, 2012 in the total amount of $155 million.
National Jewish Health is seeking to refine and improve lung-cancer screening by combining a blood test with CT imaging to detect disease earlier and more effectively. The trial combines a CT chest scan and the EarlyCDT-Lung blood test to screen for cancer, and seeks to build on recent research demonstrating that CT screening alone can reduce lung-cancer mortality.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Priya Patel, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: () - | Priya Patel, 1717 6th Ave S, Birmingham, AL 35233-1801 Ph: (800) 822-8816 |
News Archive
Charles River Laboratories International, Inc. announced today that it has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost efficient basis, the repurchase of a substantial number of its shares pursuant to that stock repurchase authorization.
In a study published in the journal PNAS scientists of the German Center for Neurodegenerative Diseases present new findings on the role of the protein Tau in certain brain diseases.
Researchers at the Johns Hopkins Kimmel Cancer Center have teased out two distinct sets of risk factors for head and neck cancers, suggesting that there are two completely different kinds of the disease.
Vertex Pharmaceuticals Incorporated today announced that it will receive $155 million in cash from two financial transactions. In the first transaction, Vertex will receive approximately $120 million in cash for the issuance of notes repayable no later than October 31, 2012 in the total amount of $155 million.
National Jewish Health is seeking to refine and improve lung-cancer screening by combining a blood test with CT imaging to detect disease earlier and more effectively. The trial combines a CT chest scan and the EarlyCDT-Lung blood test to screen for cancer, and seeks to build on recent research demonstrating that CT screening alone can reduce lung-cancer mortality.
› Verified 4 days ago
Natalie Irwin, CRNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-838-3000 Fax: 205-874-8333 | |
Mrs. Donna Lee Newell, PMHCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 100 Century Park S, Suite 206, Birmingham, AL 35226 Phone: 205-978-7800 | |
Forrest Harmon Watkins, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 100 Pilot Medical Dr Ste 300, Birmingham, AL 35235 Phone: 205-856-2284 Fax: 205-815-4777 | |
Olesea Mintsin, CRNP Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-9879 Fax: 205-975-6088 | |
Kristin Nero, CRNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 860 Montclair Rd, Suite 955, Birmingham, AL 35213 Phone: 205-332-3160 Fax: 866-702-0880 | |
Kay Mclean, Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 100 Century Park S, Suite 214, Birmingham, AL 35226 Phone: 205-978-7840 Fax: 205-978-7847 |